ArticleBiomedical materials & devices (New York, N.Y.)2025
Advances in Fibrin-Based Bioprinting for Skin Tissue Regeneration: Exploring Design, and Innovative Approaches.
Article in Biomedical materials & devices (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fibrin-Based Biomaterials in Wound Healing and Soft Tissue Regeneration: Biological Mechanisms and Clinical Applications.Gels (Basel, Switzerland) · 2026Review
- Fibrin Gel as a Versatile Biomaterial Platform in the Biomedical Landscape: Chemical, Physical, and Biological Insights.Gels (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The field of tissue engineering and regenerative medicine has made significant progress, especially in the realm of biofabrication, aiming to create functional tissues and organs for transplantation, ultimately transforming medical treatments. Fibrin, a versatile and biocompatible biomaterial derived from the clotting cascade, has emerged as a crucial component in the development of bioinks for various tissue regeneration applications. This review explores the multifaceted role of fibrin-based bioinks in promoting tissue regeneration, with a specific focus on skin tissue engineering. We describe the properties and characteristics of fibrin as a biomaterial, its potential for promoting angiogenesis, and its compatibility with mechanical design considerations. By considering key findings and insights, we emphasize the potential of fibrin-based bioinks in innovating tissue engineering strategies. This review highlights the role of fibrin-based bioinks in advancing regenerative therapies and indicates a new era of tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.